Life Sciences

Argus Safety 8.0 Released! Reporting And Integration Heaven

oracle-argus-safety-argus-8.0

 

Coinciding with the Drug Information Association’s (DIA) 51st Annual Meeting in Washington, D.C. last week, Oracle announced the newest version of its drug safety and pharmacovigilance system. Argus Safety 8.0, considered a major release, offers new features and functionality to help life sciences companies comply with ever-changing global regulatory requirements.

Life Sciences - How Artificial Intelligence Can Enhance the Clinical Data Review and Cleaning Process
How Artificial Intelligence Can Enhance the Clinical Data Review and Cleaning Process

This guide analyzes how artificial intelligence – including machine learning – can be used by pharmaceutical and medical device companies to improve the clinical data review and cleansing process.

Get the Guide

The Standard Edition of the system comes with new expedited reports (ICH E2B(R3) and FDA eVAERS) for the reporting of adverse events, and now integrates with Oracle BI Publisher and Oracle B2B gateway out-of-the-box. 

While the Enterprise Edition of system harnesses all the features from the Standard Edition, it has also boasts stronger reporting, querying, and analysis functionality by way of new and/or improved integrations.

The Japanese version of Argus Safety also has a handful of new features designed to address the regulations introduced by the Pharmaceuticals and Medical Devices Agency (PMDA).

To learn more about Oracle Argus Safety 8.0, contact our safety and pharmacovigilance team.

Leave a Reply

Your email address will not be published. Required fields are marked *

This site uses Akismet to reduce spam. Learn how your comment data is processed.

Eugene Sefanov

Sr. Marketing Manager, Industries, Perficient

More from this Author

Follow Us
TwitterLinkedinFacebookYoutubeInstagram